Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

December 28, 2018

Study Completion Date

February 8, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Clarithromycin

Twenty patients receive intraluminal clarithromycin eradication of H. pylor.

DRUG

Amoxicillin, Clarithromycin

Patients fail to achieve intraluminal eradication of H. pylori will be assigned to the oral antibiotic rescue therapies with triple therapy which contains a proton pump inhibitor, amoxicillin and clarithromycin for 14 days.

Trial Locations (1)

10449

Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT03516669 - Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter